Hospital de Terrassa
Terrassa, Barcelona, 08227, Spain
NCT Number: NCT03621176
A home-based exercise program will be implemented in three different groups of participants: advanced chronic kidney disease, end-stage renal disease in substitutive treatment hemodialysis or peritoneal dialysis. Participants will be evaluated before the program, after 3 months and after 6 months from the starting of the program. During the first 3 months the researcher will phone them weekly to reinforce the exercise habit, and during the last three months, there will be no reinforcement. Assessment will include strength, functional capacity, health-related quality of life and depressive symptoms.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Terrassa, Barcelona, 08227, Spain
Three groups of participants (advanced chronic disease not yet in substitutive treatment, end-stage renal disease patients in hemodialysis and end-stage renal disease patients in peritoneal dialysis) will enter the study. The intervention will consist of a home-based exercise program. They will be provided with a booklet and the researcher will explain personally each of the exercises to the participants. Progression will be encouraged so that the participants should find the sessions 'somewhat hard' according to the rate of perceived exertion. Reinforcement will be high during the first 3 months (weekly phone calls, visits to the nephrology department) and none during the last 3 months. Assessment will be undertaken at three-time points: baseline, after 3 months of high reinforcement and after 3 more months of no reinforcement at all.
Assessment will include strength, functional capacity, health-related quality of life, cognitive state and depressive symptoms.
The aim of the study is to assess the effectiveness of home-based exercise to improve strength, physical function, health-related quality of life, cognitive state and depressive symptoms in advanced chronic kidney disease and end-stage renal disease (hemodialysis and peritoneal dialysis). We also aim at describing all these variables in the three different groups of patients. Adherence and satisfaction with the exercise program will be recorded at the end of the study.
Additionally, interobserver reliability will be calculated, so as reliability intraobserver in different measurement conditions (dialysis vs non-dialysis days).
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
A booklet with detailed information will be provided, and the exercises will be previously reviewed with every patient by the researcher. Participants will be encouraged to perform at least 3 sessions per week and monitor their heart rate. They will be instructed that the exercises should be perceived as 'somewhat hard' from a rate of perceived exertion. Adaptations to increase the intensity of the exercises will be provided so that participants can progress in exercise intensity
Time frame: Baseline,1 week, non-dialysis day baseline,12 weeks, 24 weeks
Sit to stand to sit test 10, time to perform 10 repetitions
Time frame: Baseline,1 week, non-dialysis day baseline,12 weeks, 24 weeks
Distance covered in 6 minutes
Time frame: Baseline,1 week, non-dialysis day baseline,12 weeks, 24 weeks
Sit to stand to sit test 60, number of repetitions performed during 60 seconds
Time frame: Baseline,1 week, non-dialysis day baseline,12 weeks, 24 weeks
One leg heel rise test, number of repetitions of heel rise to measure triceps strength
Time frame: Baseline,1 week, non-dialysis day baseline,12 weeks, 24 weeks
Handgrip strength measured through a dynamometer
Time frame: Baseline,1 week, non-dialysis day baseline,12 weeks, 24 weeks
Short physical performance battery, a combination of walking speed, STS-5 and balance
Time frame: Baseline,1 week, non-dialysis day baseline,12 weeks, 24 weeks
One-leg stand test, time to keep the balance in one leg
Time frame: Baseline,1 week, non-dialysis day baseline,12 weeks, 24 weeks
Timed up and go test, time to stand up from a chair, walk 3m, turn around and sit back again
Time frame: Baseline,12 weeks, 24 weeks
Serum albumin in blood for dialysis patients
Time frame: Baseline,12 weeks, 24 weeks
Euroquol 5D questionnaire, scale 0 (worst health) to 100 (best health). 5 Dimensions include mobility, personal care, activities of daily living, pain, and anxiety/depression
Time frame: Baseline,12 weeks, 24 weeks
Questionnaire to measure depressive symptoms. Range from 0 (normal) to 63 (worst depression)
Time frame: Baseline,12 weeks, 24 weeks
Questionnaire to measure physical activity. Higher score represents higher activity. Measures of average and maximal activity scores are reported. Average activity scores bellow 53 are considered impaired; between 53 and 74 are considered moderately active and above 74 are considered active.
Time frame: Baseline,12 weeks, 24 weeks
Questionnaire to measure physical activity. Higher scores represent higher activity.
Time frame: 12 weeks, 24 weeks
Sessions performed/offered x 100
Cardenal Herrera University
Other
Effects of Home-based Exercise in Advanced Chronic Kidney Disease and End-stage Renal Disease
Acronym: HBCKD-BCN
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03354910
Chronic Disease, Chronic Kidney Disease
Boston, Massachusetts, United States
View Trial DetailsNCT02976220
Chronic Disease, Chronic Kidney Disease
San Francisco, California, United States
View Trial DetailsNCT01786525
Chronic Disease, Chronic Kidney Disease
Boston, Massachusetts, United States
View Trial DetailsNCT00785265
Chronic Disease, Chronic Kidney Disease
Boston, Massachusetts, United States
View Trial Details